πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 179 of 200 Β· A–Z by INN

  1. telavancin hydrochloride

    VIBATIV CUMBERLAND PHARMACEUTICALS INC

    INTRAVENOUS FDA: approved

  2. telbivudine

    SEBIVO

    ORAL FDA: approved Β· EMA: withdrawn Β· NMPA: clinical trials

    J05AF11
  3. telisotuzumab

    NMPA: clinical trials

  4. telisotuzumab vedotin-tllv

    EMRELIS

    SINGLE-DOSE FDA: approved

  5. telitacicept

    NMPA: clinical trials

  6. telithromycin

    KETEK

    ORAL FDA: approved Β· EMA: withdrawn

    J01FA15
  7. telmisartan

    APO-TELMISARTAN Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    C09DA07
  8. telmisartan + amlodipine

    ARX-TELMISARTAN/AMLODIPINE Alphapharm Pty Ltd

    TGA: approved

  9. telmisartan + hydrochlorothiazide

    TELTARTAN HCT 40/12.5 Alphapharm Pty Ltd

    TGA: approved

  10. telotristat ethyl

    XERMELO

    EMA: approved

    A16A
  11. telotristat etiprate

    XERMELO

    ORAL FDA: approved

  12. temazepam

    APO-TEMAZEPAM Alphapharm Pty Ltd

    ORAL FDA: approved Β· TGA: approved

  13. temoporfin

    FOSCAN

    EMA: approved

    L01XD05
  14. temozolomide

    APO-TEMOZOLOMIDE Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01AX03
  15. temsirolimus

    TORISEL

    INTRAVENOUS FDA: approved Β· EMA: approved

    L01XE09
  16. tenapanor hydrochloride

    PHOZEVEL

    ORAL FDA: approved Β· PMDA: approved

  17. tenecteplase

    METALYSE

    FDA: approved Β· EMA: approved

    B01AD11
  18. teneligliptin

    NMPA: clinical trials

  19. teneligliptin hydrobromide hydrate

    TENELIA

    PMDA: approved

  20. teniposide

    VUMON

    INJECTION FDA: approved Β· NMPA: clinical trials

  21. tenofovir alafenamide

    VEMLIDY Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ORAL FDA: approved Β· EMA: approved

    J05AF13
  22. tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat

    GENVOYA Gilead Sciences Pty Limited

    TGA: approved

  23. tenofovir alafenamide fumarate

    VEMLIDY

    ORAL FDA: approved Β· PMDA: approved

  24. tenofovir disoproxil

    TENOFOVIR ARX Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    J05AF07

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources